Statement of Retraction: Foslevodopa/foscarbidopa (LDp/CDp) in advanced Parkinson's Disease (aPD): demonstration of savings from a societal perspective in the UK
- PMID: 40923813
- DOI: 10.1080/13696998.2025.2558292
Statement of Retraction: Foslevodopa/foscarbidopa (LDp/CDp) in advanced Parkinson's Disease (aPD): demonstration of savings from a societal perspective in the UK
Retraction of
-
Foslevodopa/foscarbidopa (LDp/CDp) in advanced Parkinson's Disease (aPD): demonstration of savings from a societal perspective in the UK.J Med Econ. 2024 Jan-Dec;27(1):1267-1278. doi: 10.1080/13696998.2024.2400857. Epub 2024 Oct 1. J Med Econ. 2024. Retraction in: J Med Econ. 2025 Dec;28(1):1500. doi: 10.1080/13696998.2025.2558292. PMID: 39254803 Retracted.
Publication types
LinkOut - more resources
Full Text Sources